Search results
Results From The WOW.Com Content Network
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB. The medical standard for active TB is a short course treatment involving a combination of isoniazid , rifampicin (also known as Rifampin), pyrazinamide , and ethambutol for the first two months.
The Stop TB Initiative was established following the meeting of the First Session of the Ad Hoc Committee on the Tuberculosis Epidemic held in London in March 1998. [4] In March 2000 the Stop TB Partnership produced the Amsterdam Declaration to Stop TB, which called for action from ministerial delegations of 20 countries with the highest burden of TB.
Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to the tuberculosis (TB) control strategy recommended by the World Health Organization. [1] According to WHO, "The most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it.
Treatment for tuberculosis generally consists of antibiotics taken daily or weekly for a period of months. People with infectious tuberculosis must be isolated during that time, until they’re no ...
“The patient and her family gave us permission to share this update,” the local health department reported Monday.
Treatment for tuberculosis usually consists of antibiotics taken daily or weekly for a period of months. During that time, people with active disease must be isolated until they’re no longer ...
Treatment success rates were lower than 50% in Ukraine, Mozambique, Indonesia and India. Areas with poor TB surveillance infrastructure had higher rates of loss to follow-up of treatment. [68] Before the discovery of effective antibiotics in the early 1940s, a collapsed lung might be triggered deliberately as a treatment for tuberculosis.
Unitaid and partners have revolutionized childhood TB treatment with quality paediatric medicines that are affordable and taste good. Unitaid is also investing in better approaches to help find the one million children affected by TB each year, and to identify drug-resistant strains of TB in patients with genome-based diagnostic technologies. [5]